About us

OUR PROJECTS

RD-CONNECT

RD-Connect will develop a global infrastructure for sharing the research outputs of these and other rare disease projects, enabling scientists and clinicians worldwide to access a single centralized repository for omics data, phenotypic and biomaterial information.

Learn more about RD-Connect in the News section

BRIDGES

In this project, we aim to build a knowledge base that will allow identification of women at high-risk of breast cancer, in particular through comprehensive evaluation of DNA variants in known and suspected breast cancer genes.

Learn more about BRIDGES here

What they say
about Alamut

"We are very pleased with Alamut since it conveniently streamlines post-sequencing analyses of detected variants. We value the programme user friendliness and its all-in one approach to variant analysis."

PROF. MILAN MACEK Jr. M.D. Ph.D.
Charles University, Prague

For Research Use Only. Not for Use in Diagnostic Procedures. The information included has been prepared for and is intended for viewing by a global audience. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult local sales representatives.

© 2021 SOPHiA GENETICS. All rights reserved. All trademarks are the property of SOPHiA GENETICS and/or its affiliate(s) in the U.S. and/or other countries. All other names, logos, and other trademarks are the property of their respective owners.